在16岁前接种疫苗的人中,HPV疫苗将宫颈癌风险减少80%,并且是安全的,但由于错误信息,接种率仍然很低。 HPV vaccine cuts cervical cancer risk by 80% in those vaccinated before 16 and is safe, but uptake remains low due to misinformation.

对1.32亿人口进行的主要科克兰审查证实,HPV疫苗非常有效,将16岁之前获得的宫颈癌风险降低80%,并防止过早变化和其他与HPV有关的癌症。 A major Cochrane review of over 132 million people confirms the HPV vaccine is highly effective, reducing cervical cancer risk by 80% when given before age 16, and prevents precancerous changes and other HPV-related cancers. 疫苗安全,只有少量副作用,与生育问题或心脏病等严重的健康问题没有联系。 The vaccine, safe with only minor side effects, shows no link to serious health issues like fertility problems or heart conditions. 尽管有确凿的证据,但一些地区的疫苗接种率由于错误信息而停滞或下降,尽管在西班牙和德国等国,疫苗接种率正在上升。 Despite strong evidence, vaccination rates have stalled or declined in some areas due to misinformation, though they are rising in countries like Spain and Germany. 研究人员敦促为男孩和女孩更广泛地接种疫苗,以加强社区保护,降低全球癌症发病率,特别是在低收入国家,因为宫颈癌仍然是妇女死亡的主要原因。 Researchers urge broader vaccination for both boys and girls to enhance community protection and reduce cancer rates globally, especially in lower-income nations where cervical cancer remains a leading cause of death among women.